메뉴 건너뛰기




Volumn 26, Issue 12, 1998, Pages 53-56

Pulmonary embolism: Sifting the risk factors

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DESOGESTREL; GESTAGEN; HEPARIN; ORAL CONTRACEPTIVE AGENT; WARFARIN;

EID: 0031737470     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/psm.1998.12.1224     Document Type: Article
Times cited : (4)

References (9)
  • 1
    • 0030850123 scopus 로고    scopus 로고
    • Risk factors for venous thrombosis: Prevalence, risk, and interaction
    • Rosendaal FR: Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol 1997;34(3):171-187
    • (1997) Semin Hematol , vol.34 , Issue.3 , pp. 171-187
    • Rosendaal, F.R.1
  • 2
    • 0030757385 scopus 로고    scopus 로고
    • Oral contraceptives and thrombotic disease: Risk of venous thromboembolism
    • Helmerhorst FM, Bloemenkamp KM, Rosendaal FR, et al: Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thromb Haemost 1997;78(1):327-333
    • (1997) Thromb Haemost , vol.78 , Issue.1 , pp. 327-333
    • Helmerhorst, F.M.1    Bloemenkamp, K.M.2    Rosendaal, F.R.3
  • 3
    • 0003984768 scopus 로고    scopus 로고
    • Montvale, NJ, Medical Economics Company, Inc
    • Physicians' Desk Reference, ed 52. Montvale, NJ, Medical Economics Company, Inc, 1998, pp 2013-2020
    • (1998) Physicians' Desk Reference, Ed 52 , pp. 2013-2020
  • 4
    • 0029564931 scopus 로고
    • Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995;346(8990):1575-1582
    • (1995) Lancet , vol.346 , Issue.8990 , pp. 1575-1582
  • 5
    • 0030733181 scopus 로고    scopus 로고
    • The pill and thrombosis: Epidemiological considerations
    • Carter C: The pill and thrombosis: epidemiological considerations. Baillieres Clin Obstet Gynaecol 1997;11(3):565-585
    • (1997) Baillieres Clin Obstet Gynaecol , vol.11 , Issue.3 , pp. 565-585
    • Carter, C.1
  • 6
    • 0028029477 scopus 로고
    • Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
    • Vandenbroucke JP, Koster T, Briet E, et al: Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344(8935):1453-1457
    • (1994) Lancet , vol.344 , Issue.8935 , pp. 1453-1457
    • Vandenbroucke, J.P.1    Koster, T.2    Briet, E.3
  • 7
    • 0029948169 scopus 로고    scopus 로고
    • Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden
    • Hirsch DR, Mikkola KM, Marks PW, et al: Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J 1996;13(6):1145-1148
    • (1996) Am Heart J , vol.13 , Issue.6 , pp. 1145-1148
    • Hirsch, D.R.1    Mikkola, K.M.2    Marks, P.W.3
  • 8
    • 0030724266 scopus 로고    scopus 로고
    • Third-generation oral contraceptive and deep venous thrombosis; from epidemiologic controversy to new insight in coagulation
    • Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KM, et al: Third-generation oral contraceptive and deep venous thrombosis; from epidemiologic controversy to new insight in coagulation. Am J Obstet Gynecol 1997;177(4):887-891
    • (1997) Am J Obstet Gynecol , vol.177 , Issue.4 , pp. 887-891
    • Vandenbroucke, J.P.1    Helmerhorst, F.M.2    Bloemenkamp, K.M.3
  • 9
    • 0029007585 scopus 로고
    • Current concepts of anticoagulation therapy
    • Hull RD, Pineo GF: Current concepts of anticoagulation therapy. Clin Chest Med 1995;16(2):269-280
    • (1995) Clin Chest Med , vol.16 , Issue.2 , pp. 269-280
    • Hull, R.D.1    Pineo, G.F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.